Monthly Archives: May 2017

ATTN: Pharmacists

The Ohio State Board of Pharmacy is proposing changes to the ways in which prescriptions for controlled substances are written, hoping to impose ICD-1O codes. ICD-10 codes are based upon the International Classification of Diseases, published by the World Health Organization, which uses unique alphanumeric codes to identify diseases and other health problems. These records are used by healthcare professionals for storage assistance, and retrieval of diagnostic information; ICD records are also used in the compilation and publication of national mortality / morbidity statistics.

For those pharmacists who use e-prescribing, software updates would likely be implemented; for those who use paper prescriptions, ICD-10 codes would require additional fields. For pharmacists who do not currently include ICD-10 codes in their prescribing software or electronic medical records, they would be required to locate the accurate ICD-10 code prior to filling prescriptions. These changes would likely add to the administrative burdens of pharmacists, as they would be compelled to obtain information from prescribers or prescribers’ agents prior to prescription dispensations. Further concerns focus on privacy, whether e-prescribing systems will be able to accommodate these changes, and–perhaps most importantly–concerns that these requirements would take away significant time from patient care.

Wellness Medicine

The primary, overarching goal of the Fellowship in Metabolic and Nutritional Medicine is not only to instruct participants in the most recent developments in metabolic medicine, but also to allow them to further their professional trajectories and journeys. Many of our Fellows go on to open their own practices or change current practices; several of them write and become published; others share education and disseminate information in a variety of ways.

Nathan Goodyear, MD, one of our previous Fellows, penned an article for LinkedIn titled “What is Wellness Medicine? A life lesson.” Board-certified by the American Academy of Anti-Aging Medicine in 2010, Dr. Goodyear completed the Advanced Fellowship in addition to several electives: Pediatrics, Homeopathy, IV Therapy, Toxicology, and Weight Management. In the article, he discusses the characteristics that distinguish ‘wellness medicine,’ explaining that the very nature of this brand of medicine is defined by its focus and goal: “its focus is the patient and its goal is the healing of the patient.” Dr. Goodyear explains that wellness medicine is rooted in being proactive: working within the parameters of someone’s lifestyle, in order to prevent the manifestation of chronic disease.

Perhaps most importantly, Dr. Goodyear clarifies that wellness medicine and traditional medicine are not dichotomous, nor do they conflict with each other. Rather, the two paradigms of medicine can—and should—co-exist, as they directly complement each other. While the purpose of wellness medicine is to enact lifestyle interventions that can prevent disease, traditional medicine is critical in its evidence-based style that is necessary in both disease diagnosis and management.

To read Dr. Goodyear’s article in full, click here. Learn more about our Fellowship in Metabolic and Nutritional Medicine here.

Ushering in the Era of Personalized Medicine

The FDA recently approved 10 of the personal-genomics company 23andMe’s screening tests for hereditary health risks and diseases, issuing a press release that reads: “These are the first direct-to-consumer tests…that provide information on an individual’s genetic predisposition to certain medical diseases or conditions.”

The Wall Street Journal reports that this step “may be the first shot in a health revolution,” allowing patients to make informed decisions about lifestyle choices, and assist healthcare professionals in their advice and discussions. This marks the first time that patients will not have to go through a physician or healthcare provider to receive information about genetic health risks or makeup.

The screening tests include one for Alzheimer’s, and another for a rare blood disorder. Companies like 23andMe and PatientsLikeMe are already developing new technologies and products so that Americans can further manage and monitor their health, studying databases that utilize information from electronic medical records, wearable devices, and patient surveys combined with their genetic codes. 23andMe has formed partnerships with various organizations in the disease research community, spearheading research that explores new potential genetic risk factors for chronic disease.

Embracing this kind of precision medicine will enable us to mine enormous amounts of data and information, in order to further enhance the health of patients across the globe, and possibly halt disease before it develops and progresses.